We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

3D Printing Used to Create Degradable Microfluidic Devices

By LabMedica International staff writers
Posted on 21 Sep 2017
Print article
Image: A modified three-dimensional printing technique was used to create temporary microstructures that could be degraded on demand using a biocompatible chemical trigger (Photo courtesy of the Wong Laboratory, Brown University).
Image: A modified three-dimensional printing technique was used to create temporary microstructures that could be degraded on demand using a biocompatible chemical trigger (Photo courtesy of the Wong Laboratory, Brown University).
A team of bioengineers modified the stereolithographic three-dimensional printing technique to create a series of microfluidic devices from biocompatible and degradable materials.

The stereolithographic technique is based on a computer-guided ultraviolet laser that traces patterns across the surface of a photoactive polymer solution. The light causes the polymers to coalesce, forming covalently bound, solid three-dimensional structures within the solution. The tracing process is repeated until an entire object is built from the bottom up.

Investigators at Brown University (Providence, RI, USA) modified this technique by printing on hydrogels using noncovalent (ionic) crosslinking, which enabled reversible patterning with controlled degradation. They demonstrated the feasibility of this approach using sodium alginate, photoacid generators, and various combinations of divalent cation salts, which could be used to tune the hydrogel degradation kinetics, pattern fidelity, and mechanical properties.

The investigators described in the September 5, 2017, online edition of the journal Lab on a Chip how they used this technique to prepare template perfusable microfluidic channels within a second encapsulating hydrogel for T-junction and gradient devices. Degradable alginate barriers were used to direct collective cell migration from different initial geometries, revealing differences in front speed and leader cell formation. The presence and degradation of printed alginate microstructures were further verified to have minimal toxicity on epithelial cells.

"The idea is that the attachments between polymers should come apart when the ions are removed, which we can do by adding a chelating agent that grabs all the ions," said senior author Dr. Ian Wong, assistant professor of engineering at Brown University. "This way we can pattern transient structures that dissolve away when we want them to. We can start to think about using this in artificial tissues where you might want channels running through it that mimic blood vessels. We could potentially template that vasculature using alginate and then dissolve it away like we did for the microfluidic channels."

Related Links:
Brown University

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Blood Gas and Chemistry Analysis System
Edan i500
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: Karius Focus BAL is designed to quickly identify the etiology of lung infections and improve diagnostic yield over standard of care testing (Photo courtesy of Karius)

Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections

Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more